Pioglitazone HCL and Metformin HCL 15 mg/1

Pioglitazone HCL and Metformin HCL 15 mg/1 tablets combine two active ingredients for managing blood sugar levels. This oral medication is commonly used in diabetes care to improve insulin sensitivity and glucose control.

Pioglitazone HCL and Metformin HCL 15 mg/1 tablets are typically used to manage type 2 diabetes. Pioglitazone works by making the body more sensitive to insulin, while Metformin helps reduce glucose production in the liver. Together, they help control blood sugar levels. This combination is often prescribed when diet and exercise alone are not enough to manage diabetes effectively.

Common effects of Pioglitazone HCL and Metformin HCL 15 mg/1 tablets may include weight gain, headaches, and digestive issues like nausea or diarrhea. Some users may also experience fluid retention or mild dizziness. These effects vary and are not experienced by everyone.

Pioglitazone HCL and Metformin HCL 15 mg/1 tablets should be handled with care. It is important to follow the advice of a healthcare provider regarding diet, exercise, and regular monitoring of blood sugar levels. Avoid alcohol while taking this medication, as it can increase the risk of side effects.

Pioglitazone HCL and Metformin HCL 15 mg/1 tablets may interact with other medications, including certain antibiotics, diuretics, and drugs that affect liver enzymes. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.